Concepedia

Novartis (Norway)

N(

Statistics

Publications

94

Citations

3K

Authors

5

Location

Oslo, Norway

Novartis (Norway) is a company institution in Oslo, Norway known for medicine, everolimus-based regimens, and pharmacotherapy.

HomepageWikipediaROR

Top concepts

Publications

94

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

Hallvard Holdaas, Bengt Fellström, Alan G. Jardine et al. · The Lancet · 2003 · 925 citations

, , +12

Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial

Bert Andersson, Finn Gustafsson, Hans Eiskjær et al. · American Journal of Transplantation · 2014 · 151 citations · Full text

, , +17

Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial

Lars Gullestad, Martin Iversen, Svend-Aage Mortensen et al. · Transplantation · 2010 · 149 citations

, , +17

Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study

Bert Andersson, Finn Gustafsson, Hans Eiskjær et al. · American Journal of Transplantation · 2016 · 107 citations · Full text

, , +17

Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation

L. Mjörnstedt, Søren Schwartz Sørensen, Bengt von zur Mühlen et al. · American Journal of Transplantation · 2012 · 96 citations

, , +10

1–5 of 94

Authors

5

  1. DS
    D. Solbu

    Novartis (Norway), Norway

    47 publications · 2.2K citations

    18

    h-index

  2. ØB
    Ø. Bentdal

    Novartis (Norway), Norway

    5 publications · 102 citations

    4

    h-index

  3. IE
    I. Erikstad

    Novartis (Norway), Norway

    5 publications · 96 citations

    3

    h-index

  4. AT
    Asbjørn Toft Hornemann

    Novartis (Norway), Norway

    1 publications · 11 citations

    1

    h-index

  5. PF
    P. Foss

    Novartis (Norway), Norway

    1 publications · 32 citations

    1

    h-index

1–5 of 5